MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2025.127596

Медицинская библиотека · Vaccine · 2025

Duration of immunogenicity of four triple doses and four standard doses hepatitis B vaccine in adults infected with human immunodeficiency virus: A one-year follow-up study in China.

Gao Linying, Zhang Xiaosheng, Mo Xinyuan, Sun Yangle, Yao Tian, Li Yandi, Li Jinbo, Yang Feng, Yuan Chenli, Nie Xiaoyong, Wang Fuzhen, Feng Yongliang, Yang Jin, Liang Xiaofeng, Wang Suping

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

People infected with human immunodeficiency virus (HIV) are more likely to be infected with hepatitis B virus (HBV), which is a significant public health concern. It is essential to provide protection through the hepatitis B vaccine and to stimulate higher and more sustained levels of anti-HBs antibodies to ensure long-term immunity. We aimed to enhance the duration of immunogenicity by implementing high-dose and multiple-schedule hepatitis B vaccination in adults infected with HIV.

METHODS

This open-label, parallel-group, randomised controlled trial (RCT) was conducted between May 2020 and January 2021 at the Second Hospital of Yuncheng. Patients were randomised to receive 3 or 4 doses of 20 μg or 60 μg of hepatitis B vaccine. The follow-up period was extended to 2022 to evaluate the duration of immunogenicity.

RESULTS

The geometric mean concentration (GMC) and response rates of hepatitis B surface antibody (anti-HBs) at month 18 were 200.40 mIU/ml and 66.67 % (58/87) in the IM20 × 3 group, 382.20 mIU/ml and 75.58 % (65/86) in the IM20 × 4 group, 628.50 mIU/ml and 83.13 % (69/83) in the IM60 × 4 group, which were significantly different between the IM20 × 3 and IM60 × 4 groups (P < 0.017). In multivariate analysis, gender and vaccination regimens affected the duration of immunogenicity at month 18. Regarding the multiplicative scale, the interaction effect was significant between the male and the IM60 × 4 group after adjusting for confounders.

CONCLUSION

In the one-year follow-up (month 18) of adults infected with HIV, four triple doses regimen of hepatitis B vaccine improved the duration of immunogenicity in male patients.

Для цитирования: Gao Linying, Zhang Xiaosheng, Mo Xinyuan, Sun Yangle, Yao Tian, Li Yandi, Li Jinbo, Yang Feng, Yuan Chenli, Nie Xiaoyong, Wang Fuzhen, Feng Yongliang, Yang Jin, Liang Xiaofeng, Wang Suping. Duration of immunogenicity of four triple doses and four standard doses hepatitis B vaccine in adults infected with human immunodeficiency virus: A one-year follow-up study in China.. Vaccine. 2025. DOI: 10.1016/j.vaccine.2025.127596.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.